NovaMedica is in advanced negotiations to secure Russia and CIS rights for a wide range of innovative   Products.  We are seeking  specialty pharmaceutical drugs and devices from various potential US and European partners (including Domain Associates, Inc. portfolio companies) spanning several high-growth therapeutic areas in hospital inpatient, hospital outpatient and specialty care clinical contexts. Products  can be both FDA/EMA approved and phase 2B/3 late-stage development. Please check back regularly as we grow our pipeline to serve this exciting market.

Our news

All news

Media Center

Read more